We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

12 hedge funds and large institutions have $5.25M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 529 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

98% less funds holding

Funds holding: 546 → 12 (-534)

98% less capital invested

Capital invested by funds: $338M → $5.25M (-$333M)

100% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 529

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
12
Holders Change
-534
Holders Change %
-97.8%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
529
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
Jet Capital Investors
New York
+$2.15M
2
TNB
Thomasville National Bank
Georgia
+$146K

Top Sellers

1
PCM
Pentwater Capital Management
Florida
-$47.7M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$20.6M
3
ACM
Abrams Capital Management
Massachusetts
-$17.1M
4
FCM
Farallon Capital Management
California
-$14.8M
5
BFS
Bard Financial Services
Connecticut
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
GI
301
GS Investments
Minnesota
– -$9K -12,950 Closed
AIA
302
Affinity Investment Advisors
California
– -$9K -12,837 Closed
UR
303
USCA RIA
Texas
– -$9K -12,802 Closed
CTC
304
Central Trust Company
Missouri
– -$9K -12,483 Closed
V
305
Veritable
Delaware
– -$9K -12,428 Closed
IP
306
Intellectus Partners
California
– -$8K -12,282 Closed
IRF
307
IBM Retirement Fund
New York
– -$8K -12,260 Closed
WTC
308
WhitTier Trust Company
Nevada
– -$9K -12,066 Closed
BRWA
309
B. Riley Wealth Advisors
Florida
– -$9K -12,061 Closed
GC
310
Guggenheim Capital
Illinois
– -$8K -12,028 Closed
ATC
311
Argent Trust Co
Tennessee
– -$8K -12,019 Closed
GAM
312
Griffin Asset Management
New York
– -$8K -11,954 Closed
FHC
313
First Horizon Corporation
Tennessee
– -$7K -11,472 Closed
PAM
314
Peak Asset Management
Colorado
– -$8K -11,455 Closed
AIS
315
AM Investment Strategies
Tennessee
– -$8K -11,300 Closed
WC
316
Westhampton Capital
North Carolina
– -$8K -11,150 Closed
Jane Street
317
Jane Street
New York
– -$8K -10,968 Closed
FNBT
318
FineMark National Bank & Trust
Florida
– -$8K -10,926 Closed
Teacher Retirement System of Texas
319
Teacher Retirement System of Texas
Texas
– -$7K -10,812 Closed
S
320
Seeyond
France
– -$7K -10,786 Closed
FWCM
321
Ferguson Wellman Capital Management
Oregon
– -$7K -10,761 Closed
EWM
322
Evercore Wealth Management
New York
– -$7K -10,722 Closed
SF
323
Synovus Financial
Georgia
– -$5K -10,715 Closed
N
324
Nuveen
North Carolina
– -$7K -10,700 Closed
MCM
325
Maple Capital Management
Vermont
– -$7K -10,624 Closed
11 12
13
14 15

BMY.RT Hedge Fund Activity: Q1 2021 in Review

12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q1 2021, worth a combined $5.25M — down 98% from $338M a quarter earlier.

Sellers outnumbered buyers: 529 funds closed out of BMY.RT and 2 opened new positions — a net loss of 527 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Jet Capital Investors, adding an estimated $2.15M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $47.7M sold.

  • 12 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q1 2021, down from 546 in Q4 2020.
  • Funds reported $5.25M of Bristol-Myers Squibb Company Contingent Value Rights stock for Q1 2021, down 98% quarter-over-quarter.
  • 2 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q1 2021 and 529 closed out, a net change of -527 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q1 2021 was Jet Capital Investors, an estimated $2.15M added.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q1 2021 was Pentwater Capital Management, an estimated $47.7M sold.

Based on aggregated 13F filings for Q1 2021.